KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Acadia Pharmaceuticals (ACAD) over the last 15 years, with Sep 2025 value amounting to $8.1 million.

  • Acadia Pharmaceuticals' Other Working Capital Changes rose 47.82% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 31.49%. This contributed to the annual value of $16.6 million for FY2024, which is 6.23% down from last year.
  • As of Q3 2025, Acadia Pharmaceuticals' Other Working Capital Changes stood at $8.1 million, which was up 18,356.82% from $44,000 recorded in Q2 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Other Working Capital Changes peaked at $19.9 million during Q3 2023, and registered a low of -$5.6 million during Q2 2023.
  • Moreover, its 3-year median value for Other Working Capital Changes was $3.3 million (2024), whereas its average is $3.6 million.
  • As far as peak fluctuations go, Acadia Pharmaceuticals' Other Working Capital Changes tumbled by 298.68% in 2021, and later soared by 1,101.21% in 2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$1.4 million in 2021, then crashed by 40.89% to -$2.0 million in 2022, then spiked by 158.30% to $1.1 million in 2023, then soared by 262.05% to $4.1 million in 2024, then soared by 47.82% to $8.1 million in 2025.
  • Its last three reported values are $8.1 million in Q3 2025, $44,000 for Q2 2025, and -$3.0 million during Q1 2025.